These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18786914)

  • 21. Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group.
    Gheorghiade M; Adams KF; Cleland JG; Cotter G; Felker GM; Filippatos GS; Fonarow GC; Greenberg BH; Hernandez AF; Khan S; Komajda M; Konstam MA; Liu PP; Maggioni AP; Massie BM; McMurray JJ; Mehra M; Metra M; O'Connell J; O'Connor CM; Pang PS; Piña IL; Sabbah HN; Teerlink JR; Udelson JE; Yancy CW; Zannad F; Stockbridge N;
    Am Heart J; 2009 Jun; 157(6):957-70. PubMed ID: 19464405
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tailored drug therapy in heart failure--a future vision. Biological markers can support individually directed treatment].
    Dahlström U
    Lakartidningen; 2009 Oct 14-20; 106(42):2674-5. PubMed ID: 19967945
    [No Abstract]   [Full Text] [Related]  

  • 23. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.
    Kelly D; Squire IB; Khan SQ; Quinn P; Struck J; Morgenthaler NG; Davies JE; Ng LL
    J Card Fail; 2008 Nov; 14(9):739-45. PubMed ID: 18995178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure.
    Dieplinger B; Gegenhuber A; Struck J; Poelz W; Langsteger W; Haltmayer M; Mueller T
    Clin Chim Acta; 2009 Feb; 400(1-2):91-6. PubMed ID: 19000665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers in heart failure. Preface.
    Braunwald E
    Heart Fail Clin; 2009 Oct; 5(4):xiii-xiv. PubMed ID: 19631171
    [No Abstract]   [Full Text] [Related]  

  • 26. The anemia of heart failure.
    Silverberg DS; Wexler D; Palazzuoli A; Iaina A; Schwartz D
    Acta Haematol; 2009; 122(2-3):109-19. PubMed ID: 19907148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-type natriuretic peptide-a CPK for heart-failure and beyond (ischemia)?
    Arora V; Bhandari S
    Indian Heart J; 2006; 58(2):90-2. PubMed ID: 18989049
    [No Abstract]   [Full Text] [Related]  

  • 28. [Erythropoietin in patients with chronic heart failure].
    Makarova NA; Shaposhnik II; Zakharov IuM
    Klin Med (Mosk); 2009; 87(3):31-4. PubMed ID: 19469252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
    Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Desmin as predictor of survival in patients with chronic heart failure].
    Wojnicz R
    Kardiol Pol; 2009 Jul; 67(7):734. PubMed ID: 19750605
    [No Abstract]   [Full Text] [Related]  

  • 31. Death and dying in heart failure with normal ejection fraction.
    Lim HS; Beadle R; Frenneaux M
    Am J Cardiol; 2009 Nov; 104(9):1311-4. PubMed ID: 19840583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sepsis and those who are "weak of heart".
    van Kimmenade RR; Bajwa E; Januzzi JL
    Crit Care Med; 2008 Nov; 36(11):3108-9. PubMed ID: 18941317
    [No Abstract]   [Full Text] [Related]  

  • 33. Newer biomarkers in heart failure.
    Gupta S; Drazner MH; de Lemos JA
    Heart Fail Clin; 2009 Oct; 5(4):579-88. PubMed ID: 19631181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the brain natriuretic peptide in heart failure management.
    Kalsmith BM
    Circ Heart Fail; 2009 Jul; 2(4):379. PubMed ID: 19808363
    [No Abstract]   [Full Text] [Related]  

  • 35. [Investigation of the morphofunctional properties of human red blood cells under the conditions of 7-day dry immersion].
    Ivanova SM; Morukov BV; Maksimov GV; Bryzgalova NIu; Labetskaia OI; Iarlykova OI; Levina AA
    Aviakosm Ekolog Med; 2009; 43(1):43-7. PubMed ID: 19462781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natriuretic peptides: putting the evidence into practice.
    Andrade A; Sharar H
    Can J Cardiovasc Nurs; 2008; 18(4):34-9. PubMed ID: 19093420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Troponin and heart failure: an early warning system worth listening to?
    Sundström J
    Future Cardiol; 2009 Jul; 5(4):321-4. PubMed ID: 19656055
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.
    Yamaji M; Tsutamoto T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
    Circ Heart Fail; 2009 Nov; 2(6):608-15. PubMed ID: 19919986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of b-type natriuretic peptide in heart failure management.
    Newton PJ; Betihavas V; Macdonald P
    Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Dose-dependent" impact of recurrent cardiac events on mortality in patients with heart failure.
    Lee DS; Austin PC; Stukel TA; Alter DA; Chong A; Parker JD; Tu JV
    Am J Med; 2009 Feb; 122(2):162-169.e1. PubMed ID: 19100960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.